FindTrial
Sign In

Effect of Intravenous lidocaine on opioid consumption in Video-Assisted Thoracoscopic Surgery

Effect of Intravenous lidocaine on opioid consumption in Video-Assisted Thoracoscopic Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20181211001
Enrollment
40
Registered
2018-12-11
Start date
2018-03-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

&#45

Interventions

not receive intravenous lidocaine,intravenous lidocaine 1.5 mg/kg bolus then drp 1.5 mg/kg/hr until complete skin closure
No Intervention Drug,Experimental Drug
control,intravenous lidocaine

Sponsors

none
Lead Sponsor
none,none
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: - anticipated - Video-assisted thoracoscopic surgery

Exclusion criteria

Exclusion criteria: - liver disease - denial - allergy to lidocaine - chronic pain disease - active cardiac or neurodisease

Design outcomes

Primary

MeasureTime frame
total opioid requirement 1,6,24,48 hr scale—

Secondary

MeasureTime frame
Side effect of opioid and lidocaine 1,6,24,48 hr category—

Countries

thailand

Contacts

Public Contactnatchada supakitjarern

department of anesthesiology

natchada_s@hotmail.com0631933665

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026